Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Madrigal Pharmaceuticals (MDGL) Short-term Investments (2019 - 2025)

Historic Short-term Investments for Madrigal Pharmaceuticals (MDGL) over the last 14 years, with Q3 2025 value amounting to $814.1 million.

  • Madrigal Pharmaceuticals' Short-term Investments rose 628.14% to $814.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $814.1 million, marking a year-over-year increase of 628.14%. This contributed to the annual value of $826.2 million for FY2024, which is 5466.25% up from last year.
  • Per Madrigal Pharmaceuticals' latest filing, its Short-term Investments stood at $814.1 million for Q3 2025, which was up 628.14% from $610.8 million recorded in Q2 2025.
  • Over the past 5 years, Madrigal Pharmaceuticals' Short-term Investments peaked at $826.2 million during Q4 2024, and registered a low of $27.2 million during Q4 2022.
  • In the last 5 years, Madrigal Pharmaceuticals' Short-term Investments had a median value of $263.0 million in 2021 and averaged $384.9 million.
  • In the last 5 years, Madrigal Pharmaceuticals' Short-term Investments tumbled by 8836.92% in 2022 and then soared by 186222.59% in 2023.
  • Quarter analysis of 5 years shows Madrigal Pharmaceuticals' Short-term Investments stood at $234.1 million in 2021, then crashed by 88.37% to $27.2 million in 2022, then surged by 1862.23% to $534.2 million in 2023, then surged by 54.66% to $826.2 million in 2024, then fell by 1.47% to $814.1 million in 2025.
  • Its Short-term Investments stands at $814.1 million for Q3 2025, versus $610.8 million for Q2 2025 and $659.4 million for Q1 2025.